Skip to main content

Table 4 Hepatologists’ attitude towards the use of combination tools for diagnosis of significant fibrosis and cirrhosis

From: Role of liver biopsy versus non-invasive biomarkers for diagnosis of significant fibrosis and cirrhosis: a web-based survey

Variable Patients (n = 573)
Do you use combinations of serum biomarkers and radiological methods for non-invasive assessment of hepatic fibrosis? %
 Extremely likely (100%) 13.20
 Very likely (75%) 26.17
 Moderately likely (50%) 15.88
 Slightly likely (25%) 23.27
 Not at all likely (0%) 21.48
Do you think combinations of methods are more beneficial for non-invasive assessment of hepatic fibrosis than using a single method? %
 Extremely likely (100%) 31.1
 Very likely (75%) 34
 Moderately likely (50%) 21.70
 Slightly likely (25%) 10.29
 Not at all likely (0%) 2.91
Which method do you think is easier to use for the assessment of hepatic fibrosis? %
 Liver biopsy 5.37
 Radiological methods 40.27
 Serum biomarkers 24.16
 Combination of non-invasive methods 30.20